NJ State Employees Deferred Compensation Plan continued to hold its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,000 shares of the medical instruments supplier’s stock at the end of the second quarter. NJ State Employees Deferred Compensation Plan’s holdings in DENTSPLY SIRONA were worth $389,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. boosted its position in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after buying an additional 4,950,337 shares in the last quarter. Clearbridge Investments LLC boosted its position in shares of DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at about $64,184,000. Finally, Renaissance Technologies LLC boosted its position in shares of DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after buying an additional 742,700 shares in the last quarter. Institutional investors own 95.13% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded down 0.60% on Friday, reaching $52.85. 1,573,864 shares of the company’s stock traded hands. DENTSPLY SIRONA Inc. has a 12-month low of $52.73 and a 12-month high of $65.68. The stock has a 50 day moving average price of $61.35 and a 200 day moving average price of $62.19. The stock’s market cap is $12.13 billion.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. During the same period in the previous year, the business posted $0.76 EPS. The business’s revenue was down 2.9% compared to the same quarter last year. Analysts forecast that DENTSPLY SIRONA Inc. will post $2.69 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -10.09%.
TRADEMARK VIOLATION NOTICE: This story was first posted by BNB Daily and is the property of of BNB Daily. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/nj-state-employees-deferred-compensation-plan-maintains-stake-in-dentsply-sirona-inc-nasdaqxray-updated.html.
XRAY has been the topic of a number of recent research reports. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $60.00 to $55.00 in a report on Tuesday, May 23rd. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective on the stock in a report on Thursday, July 13th. Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. BidaskClub cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Finally, HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $66.25.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.